Stryker opens Neurovascular lab to accelerate stroke-related innovation in Asia Pacific
Stroke is a leading cause of death and disability worldwide, with more than 58 million of those cases recorded in Asia.
Gurugram: Stryker, a medical technology company, has recently opened its Neurovascular (NV) lab, a state-of-the-art lab designed to accelerate stroke-related innovation in Asia Pacific.
Located within the Stryker Global Technology Center (SGTC) at International Park, Gurgaon, India, the Keystone Suite will enable collaboration between customers, product development engineers, cross-functional teams, and other key stakeholders.
Stroke is a leading cause of death and disability worldwide, with more than 58 million of those cases recorded in Asia. In India, scarcity of professional care and infrastructure are key factors in the country's treatment rates. This lab offers an ideal environment for medical education, research and development, and customer engagement activities designed to improve patient outcomes.
Read also: Medical device maker Stryker gets US antitrust nod to buy Wright Medical Group
The NV lab has three main components: a neurovascular catheterization lab designed to mimic the hospital treatment experience with the latest imaging and communication equipment; a performance lab with hands-on stations outfitted with flow models, neurovascular simulators, and 3D model printing capabilities; and planned space for physician interaction.
Read also: Medical device maker Stryker to buy Vocera Communications for 2.97 Billion USD
Mark O'Brien, Vice President and General Manager for the Neurovascular Division at Stryker, said, "Asia Pacific is our fastest growing region, and a big part of our future growth plans. We are continuing to invest in the region to facilitate innovation and advance stroke care."
Ram Rangarajan, Vice President of Stryker Global Technology Center, said, "We're excited to bring this advanced lab and its capabilities to India's neurointerventionalist community and to help grow the specialty in country. We believe in the concept of public-private partnerships and invite the government to collaborate with us to train future physicians."
Stryker established its first R&D facility in India more than 15 years ago.
Read also: Stryker India MD Meenakshi Nevatia joins APACMed as Chairperson for India Executive Committee
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.